MADISON, Wis.–(BUSINESS WIRE)–Lumicera Health Services today announced the launch of Clarventa, a new company created to address one of the most persistent drivers of rising prescription drug costs: complex and opaque drug supply chains.
Clarventa is focused on increasing the transparency, efficiency, and sustainability of pharmaceutical purchasing and supply chain services across the pharmacy ecosystem. Clarventa helps market participants operate with more confidence in an increasingly complex environment by creating clearer access paths and more predictable purchasing models.
“Cralventa is a natural extension of Lumicera’s mission to bring clarity and fairness to the way medicines are priced and delivered,” said Ben Heiser, CEO of Lumicella. “We have proven that a transparent cost-plus model works in specialty pharmacy. With Clarventa, we are applying the same principles to drug purchasing and supply chain, an area where a lack of visibility continues to create unnecessary cost and complexity for pharmacies, manufacturers, and ultimately patients.”
Clarventa and Lumicera are part of the Navitus Health Solutions family of companies, united by a shared commitment to transparent, patient-centered healthcare. For nearly 25 years, Navitus Health Solutions has been an industry pioneer, challenging traditional models, asserting clarity, and delivering innovative clinical-based solutions that reduce costs for members, sponsors, and health plans.
Navitus created the first pharmacy benefit manager (PBM) to operate with full transparency and 100% pass-through pricing, rejecting hidden markups and refusing to retain manufacturer rebates. This approach fundamentally challenged traditional PBM practices by aligning incentives with plan sponsors and members rather than drug price inflation.
The same philosophy was then extended to specialty pharmacy with the launch of Lumicera, the industry’s first cost-plus specialty pharmacy. Because Lumicera charges only the actual acquisition cost of the drug and a clearly defined patient management fee, we provide our clients and members with unprecedented insight into specialty drug costs while maintaining high-touch clinical care.
In 2023, Navitus strengthened its clinical and analytical capabilities in specialty medicine management with the acquisition of Archimedes, deepening the organization’s ability to provide monitoring, analysis and program design in one of the most complex and expensive areas of healthcare.
Clarventa builds on this foundation by addressing two other important sources of cost and complexity: drug purchasing and the drug supply chain itself.
-
For pharmacies, Clarventa increases access and purchasing power and creates sustainable contracting models.
-
For manufacturers and wholesalers, Clarventa enables access through streamlined contracts, creating transparent contracts with clearer data flows.
-
For the industry, these improvements are consistent with expanded state and federal efforts to promote point-of-sale affordability and pharmacy reimbursement consistency for healthcare consumers.
“Pharmacies, manufacturers and wholesalers all play a critical role in patient access, but too often the system creates friction rather than coordination,” said David Fields, CEO of Navitus Health Solutions. “Clarventa reduces that friction by providing clarity on how medicines are priced and purchased, while supporting affordability and equity. As our industry continues to evolve, Clarventa is an important step in increasing transparency across the pharmaceutical supply chain.”
About Lumicella Health Services:
Lumicera Health Services, a leading specialty pharmacy solutions provider, is a wholly owned subsidiary of Navitus Health Solutions, owned by SSM Health and Costco Wholesale Corp. Founded in 2014, Lumicera is committed to improving specialty pharmacy care one patient at a time through educational, clinical, financial and service excellence. Lumicera brings clinicians closer to patients and drives positive outcomes through innovative practices and strategic partnerships. For more information, please visit lumicera.com.
About Navitus Health Solutions
Navitus Health Solutions is a pioneering pharmacy solutions provider that first launched a transparent pharmacy benefit manager (PBM) to pass 100% of negotiated drug rebates and discounts to health plans and plan sponsors. Navitus PBM is an alternative to traditional PBMs that convert rebates and discounts into profits. Navitus is a pioneer in driving meaningful cost savings to make medicines more affordable. Now, nearly 25 years later, the organization offers a variety of solutions through its portfolio brands, including Navitus, Lumicera Health Services, Archimedes, and Clarventa. Navitus Health Solutions, owned by SSM Health and Costco Wholesale Corp., serves more than 18 million lives across 800 customers, including employers, unions, government plans, payers and health plans. For more information, please visit navitus.com.
#Lumicera #Health #Services #launches #Clarventa